Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP848914.RATcGKMJ-1x-fg4Hdqu_g9ByyclnOQEIU-edpkYsPaRz0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP848914.RATcGKMJ-1x-fg4Hdqu_g9ByyclnOQEIU-edpkYsPaRz0130_assertion type Assertion NP848914.RATcGKMJ-1x-fg4Hdqu_g9ByyclnOQEIU-edpkYsPaRz0130_head.
- NP848914.RATcGKMJ-1x-fg4Hdqu_g9ByyclnOQEIU-edpkYsPaRz0130_assertion description "[Here we report the identification of a secondary mutation in ALK, F1174L, as one cause of crizotinib resistance in a patient with an inflammatory myofibroblastic tumor (IMT) harboring a RANBP2-ALK translocation who progressed while on crizotinib therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP848914.RATcGKMJ-1x-fg4Hdqu_g9ByyclnOQEIU-edpkYsPaRz0130_provenance.
- NP848914.RATcGKMJ-1x-fg4Hdqu_g9ByyclnOQEIU-edpkYsPaRz0130_assertion evidence source_evidence_literature NP848914.RATcGKMJ-1x-fg4Hdqu_g9ByyclnOQEIU-edpkYsPaRz0130_provenance.
- NP848914.RATcGKMJ-1x-fg4Hdqu_g9ByyclnOQEIU-edpkYsPaRz0130_assertion SIO_000772 21030459 NP848914.RATcGKMJ-1x-fg4Hdqu_g9ByyclnOQEIU-edpkYsPaRz0130_provenance.
- NP848914.RATcGKMJ-1x-fg4Hdqu_g9ByyclnOQEIU-edpkYsPaRz0130_assertion wasDerivedFrom befree-2016 NP848914.RATcGKMJ-1x-fg4Hdqu_g9ByyclnOQEIU-edpkYsPaRz0130_provenance.
- NP848914.RATcGKMJ-1x-fg4Hdqu_g9ByyclnOQEIU-edpkYsPaRz0130_assertion wasGeneratedBy ECO_0000203 NP848914.RATcGKMJ-1x-fg4Hdqu_g9ByyclnOQEIU-edpkYsPaRz0130_provenance.